About Us Products Publications Contact
     

 
 
Publications

Lassila R, Jouppila A. Mast cell-derived heparin proteoglycans as a model for a local antithrombotic. Semin Thromb Hemost. 2014 Nov;40(8):837-44.

Olsson E, Asko-Seljavaara S, Lassila R. Topically administered macromolecular heparin proteoglycans effectively inhibit thrombus growth in microvascular anastomoses. Thromb Haemost, 87;245-51,2002

Kauhanen P, Kovanen PT, Lassila R. Coimmobilized native macromolecular heparin proteoglycans strongly inhibit platelet interactions under flowing blood. Arterioscler Thromb Vasc Biol, 20:e113-e119, 2000

Kauhanen P, Kovanen PT, Reunala T, Lassila R. Effects of cutaneous mast cells on bleeding time and coagulation activation at the site of platelet plug formation. Thromb Haemost, 79:843-7,1998.

Lassila R, Lindstedt K, Kovanen PT. Native macromolecular heparin proteoglycans exocytosed from stimulated rat serosal mast cells strongly inhibit platelet-collagen interactions. Arterioscler Thromb Vasc Biol, 17:3578-87, 1997


      © Aplagon Oy 2015